$VXRT ... sounds like no clear-cut vaccine leader or frontrunners yet. Don't think it's Oxford and certainly not Moderna based on this article just out ... Vaxart in game and possibly dark horse to win with tablet and mucosal response. GO, GO, GO VAXART statnews.com/2020/05/19/vac... "... The company’s stock valuation also surged, hitting $29 billion, an astonishing feat for a company that currently sells zero products. But was there good reason for so much enthusiasm? Several vaccine experts asked by STAT concluded that, based on the information made available by the Cambridge, Mass.-based company, there’s really no way to know how impressive — or not — the vaccine may be. While Moderna blitzed the media, it revealed very little information — and most of what it did disclose were words, not data. That’s important: If you ask scientists to read a journal article, they will scour data tables, not corporate statements. With science, numbers speak much louder than words."